Hepatic resection for colorectal metastases: value for risk scoring systems?

Area of Science:

• Oncology
• Surgical Oncology
• Clinical Research

Background:

• Predicting outcomes for metastatic colorectal cancer (mCRC) patients remains challenging due to inconsistent data.
• Existing prognostic models for mCRC lack robust validation and general applicability.

Purpose of the Study:

• Identify key predictors of survival and recurrence in mCRC patients.
• Develop a novel prognostic scoring system for mCRC.
• Evaluate the clinical utility of current major risk scoring systems in mCRC.

Main Methods:

• Retrospective review of 662 mCRC patients undergoing liver metastasis resection (1960-1995).
• Analysis of clinicopathologic variables and outcomes using univariate and multivariate methods.
• Validation of existing scoring systems using an independent dataset and comparison with a proposed Mayo model.

Main Results:

• Overall 5-year survival was 37%, with disease-specific survival at 42%; 5-year recurrence probability was 65%.
• Perioperative blood transfusion and positive hepatoduodenal nodes emerged as major determinants of survival and recurrence.
• Existing risk scoring systems demonstrated limited ability to stratify patient outcomes, performing marginally better than chance.

Conclusions:

• Current risk scoring systems possess limited clinical value for broad application in mCRC.
• Refinement and external validation of prognostic models are crucial before clinical utilization for mCRC patients.